Lilly expands insulin affordability options with lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen®
- Tuesday, January 14, 2020, 7:16
- Environment
- Add a comment
INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by introducing lower-priced versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine…
About the Author
adminasapcorp has written 41802 stories on this site.